Secretion of VGF relies on the interplay between LRRK2 and post-Golgi v-SNAREs.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
28 03 2023
Historique:
received: 05 10 2021
revised: 12 01 2023
accepted: 20 02 2023
medline: 3 4 2023
pubmed: 12 3 2023
entrez: 11 3 2023
Statut: ppublish

Résumé

The neuropeptide VGF was recently proposed as a neurodegeneration biomarker. The Parkinson's disease-related protein leucine-rich repeat kinase 2 (LRRK2) regulates endolysosomal dynamics, a process that involves SNARE-mediated membrane fusion and could regulate secretion. Here we investigate potential biochemical and functional links between LRRK2 and v-SNAREs. We find that LRRK2 directly interacts with the v-SNAREs VAMP4 and VAMP7. Secretomics reveals VGF secretory defects in VAMP4 and VAMP7 knockout (KO) neuronal cells. In contrast, VAMP2 KO "regulated secretion-null" and ATG5 KO "autophagy-null" cells release more VGF. VGF is partially associated with extracellular vesicles and LAMP1+ endolysosomes. LRRK2 expression increases VGF perinuclear localization and impairs its secretion. Retention using selective hooks (RUSH) assays show that a pool of VGF traffics through VAMP4+ and VAMP7+ compartments, and LRRK2 expression delays its transport to the cell periphery. Overexpression of LRRK2 or VAMP7-longin domain impairs VGF peripheral localization in primary cultured neurons. Altogether, our results suggest that LRRK2 might regulate VGF secretion via interaction with VAMP4 and VAMP7.

Identifiants

pubmed: 36905628
pii: S2211-1247(23)00232-2
doi: 10.1016/j.celrep.2023.112221
pii:
doi:

Substances chimiques

R-SNARE Proteins 0
SNARE Proteins 0
VGF peptide 0
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

112221

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Francesca Filippini (F)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France.

Sébastien Nola (S)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France.

Ahmed Zahraoui (A)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France.

Kevin Roger (K)

Université Paris Cité, Proteomics Platform Necker, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, 75015 Paris, France.

Mansoore Esmaili (M)

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

Ji Sun (J)

Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

José Wojnacki (J)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France.

Anaïs Vlieghe (A)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France.

Philippe Bun (P)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, NeurImag Imaging Facility, 75014 Paris, France.

Stéphanie Blanchon (S)

Hybrigenics Services, 91000 Évry-Courcouronnes, France.

Jean-Christophe Rain (JC)

Hybrigenics Services, 91000 Évry-Courcouronnes, France.

Jean-Marc Taymans (JM)

Université de Lille, INSERM, CHU Lille, UMR-S1172, LilNCog - Lille Neuroscience & Cognition, Lille, France.

Marie-Christine Chartier-Harlin (MC)

Université de Lille, INSERM, CHU Lille, UMR-S1172, LilNCog - Lille Neuroscience & Cognition, Lille, France.

Chiara Guerrera (C)

Université Paris Cité, Proteomics Platform Necker, Structure Fédérative de Recherche Necker, INSERM US24/CNRS UMS3633, 75015 Paris, France.

Thierry Galli (T)

Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, Membrane Traffic in Healthy & Diseased Brain, 75014 Paris, France; GHU Paris Psychiatrie & Neurosciences, Paris, France. Electronic address: thierry.galli@inserm.fr.

Articles similaires

1.00
Animals Inflammation Mice Membrane Proteins Humans
Golgi Apparatus Computational Biology Humans Deep Learning
Golgi Apparatus Saccharomyces cerevisiae Proteins Saccharomyces cerevisiae Membrane Proteins Proteolysis

Specialized contact sites regulate the fusion of chlamydial inclusion membranes.

Christine Linton, Jordan Wesolowski, Anna Lobley et al.
1.00
Chlamydia trachomatis Inclusion Bodies Membrane Fusion HeLa Cells Humans

Classifications MeSH